Catalyst Wire Dossier Catalyst Wire Dossier

TetraVax-DV TV005

tetravalent dengue virus vaccine TV005 · TetraVax
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TetraVax-DV TV005, covering 2025-01-17 to 2025-01-17. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Immunogenicity of the Dengue Virus Vaccine TV005 (TetraVax-DV TV005) in Healthy Adults, Adolescents, and Children in Dhaka, Bangladesh [Phase 2]

See pricing